Molecular Partners AG (MOLN) Earnings Date & Reports
Molecular Partners AG is a clinical stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MOLN is expected to report earnings to rise 2.73% to -44 cents per share on October 29
Q3'26
Est.
$-0.45
Q2'26
Beat
by $0.01
Q1'26
Missed
by $0.28
Q4'25
Missed
by $0.04
Q3'25
Beat
by $0.08
The last earnings report on August 25 showed earnings per share of -43 cents, beating the estimate of -44 cents. With 400.00 shares outstanding, the current market capitalization sits at 172.70M.